Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12167683 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Antifungal Use in Oncohematological Neutropenic Patients
Condition: Invader Fungal Infection
Intervention: Drug: Antifungal drug. VORICONAZOL. (VFEND®)
2 Completed Voriconazole Blood Levels and Toxicity
Condition: Pharmacology
Intervention:

Indicates status has not been verified in more than two years